Critically attained threshold of cerebral hypoperfusion: Can it cause Alzheimer's disease?

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 424-436

  De La Torre, J C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; BIOSYNTHESIS; BRAIN BLOOD FLOW; BRAIN PERFUSION; COGNITION; CONFERENCE PAPER; ENERGY METABOLISM; GLUCOSE TRANSPORT; HUMAN; MICROVASCULATURE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OXYGEN TRANSPORT; PATHOGENESIS; RAT; RISK FACTOR; SENILE PLAQUE; SYNAPSE; VASCULAR DISEASE;

EID: 0034064133     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06394.x     Document Type: Conference Paper

References (63)

1. 1. ABDOLLAHIAN, N.P., A. CADA, F. GONZALEZ-LIMA & J.C. DE LA TORRE. 1998. Cytochrome oxidase: a predictive marker of neurodegeneration. In Cytochrome Oxidase in Neuronal Metabolism and Alzheimer's Disease. F. Gonzalez-Lima, Ed.: 233-261. Plenum Press. New York.
2. 2. BARTENSTEIN, P., S. MINOSHIMA, C. HIRSCH & K. BUCH. 1997. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease. J. Nucl. Med. 38: 1095-1101.
3. 3. BENSON, D.F., D. KUHL, R. HAWKINS, M. PHELPS, F. CUMMINGS & Y. TSAI. 1983. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol. 40: 711-714.
4. 4. BLASS, J.P. 1993. Pathophysiology of the Alzheimer's syndrome. Neurology (Suppl. 4): S25-S38.
5. 5. BOTET, J.P., M. SENTI, X. NOGUES, J. RUBIES-PRAT, J. ROQUER, L. DOLHABERRIAGUE & J. OLIVE. 1992. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Stroke 23: 1556-1562.
6. 6. BRETELER, M.M. 1998. Epidemiological evidence of a connection between Alzheimer's disease and vascular dementia. Neurobiol. Aging 19: S150.
7. 7. BUÉE, L., P.R. HOF, C. BOURAS, A. DELACOURTE, D. PERL, J.H. NORRISON & H.M. FILLIT. 1994. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related demented disorders. Acta Neuropathol. 87: 469-480.
8. 8. CELSIS, P., A. AGNIEL, D. CARDEBAT, J.F. DEMONET, P. OUSSET & M. PUEL. 1997. Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. J. Neurol. Neurosurg. Psychiatry 62: 601-608.
9. 9. CHEMTOB, S., K. BEHARRY, T. BARNA, B.R. VARMA & J.V. ARANDA. 1991. Differences in the effects of newborn piglet of various non-steroidal anti-inflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins. Ped. Res. 30: 106-111.
10. 10. CHEN, Y, S. WEII, Z. MOURELATOS, J. GONATAS, K. OKAMOTO & N.K. GONATAS. 1998. The fragmented neuronal Golgi apparatus in ALS includes the trans-Golgi-network: functional implications. Acta Neuropathol. 95: 245-253.
11. 11. DAVIGNON, J., R.E. GREGG & C.F. SING. 1988. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8: 1-21.
12. 12. DE JONG, G.I., E. FARKAS, J. PLASS, J.N. KEIJSER, J.C. DE LA TORRE & P.G.M. LUITEN. 1999. Cerebral hypoperfusion yields capillary damage in hippocampus CA1 that correlates to spatial memory impairment. Neuroscience. In press.
13. 13. DE LA TORRE, J.C. 1994. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci. Behav. Rev. 18: 397-401.
14. 14. DE LA TORRE, J.C. 1992. Does brain microvessel pathology provoke Alzheimer's disease? Soc. Neurosci. Abstr. 18: 564.
15. 15. DE LA TORRE, J.C., A. CADA, N. NELSON, R.J. SUTHERLAND & F. GONZALEZ-LIMA. 1997. Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats. Neurosci. Lett. 223:165-168.
16. 16. DE LA TORRE, J.C. 1997. Cerebromicrovascular pathology in Alzheimet's disease compared to normal aging. Gerontology 43: 26-43.
17. 17. DE LA TORRE, J.C. 1997. Cerebrovascular changes in the aging brain. Adv. Cell Aging Gerontol. 2: 77-107.
18. 18. DE LA TORRE, J.C. & T. MUSSIVAND. 1993. Can disturbed brain microcirculation cause Alzheimer's disease? Neurol. Res. 15: 146-153.
19. 19. DE LA TORRE, J.C. 1997. Hemodynamic consequences of deformed microvesseles in the brain in Alzheimer's disease. Ann. N.Y. Acad. Sci. 826: 75-91.
20. 20. DE LEON, M.J., A. CONVIT, S. DESANTI & M. BOBINOSKI. 1997. Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. Int. Psychogeriatrics 9: 183-190.
21. 21. DEL ZOPPO, G.J. 1997. Microvascular responses to cerebral ischemia/inflammation. Ann. N.Y. Acad. Sci. 823: 132-147.
22. 22. DUARA, R., W.W. BARKER, J. CHANG & F. YOSHII. 1992. Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer's disease. J. Cerebr. Blood Flow Metab. 12: 927-934.
23. 23. ERECINSKA, M. & I. SILVER. 1989. ATP and brain function. J. Cerebr. Blood Flow Metab. 9: 2-12.
24. 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27: 1333-1337.
25. 25. HATANPAA, K., K. CHANDRASEKARAN, D.R. BRADY & S.I. RAPOPORT. 1998. No association between Alzheimer plaques and decreased levels of cytochrome oxidase unit mRNA, a marker of neuronal energy metabolism. Brain Res. Mol. Brain Res. 59: 13-21.
26. 26. HOFMAN, A., A. OTT, M. BRETELER, M. BOTS, A. SLOOTER & D. GROBBEE. 1997. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349:151-154.
27. 27. HOLSCHNEIDER, D.P. & O.U. SCREMIN. 1998. Effects of ovariectomy on cerebral flow in rats. Neuroendocrinology 67: 260-268.
28. 28. HOYER, S. 1986. Senile dementia and Alzheimer's disease, brain blood flow and metabolism. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 10: 447-478.
29. 29. HOYER, S. 1991. Brain energy metabolism and its significance for Alzheimer's disease; In Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies. K. Iqbal, D.R.C. McLachlan, B. Winblad & H.M. Wisniewski, Eds. :53-57. Wiley. New York.
30. 30. JOHNSON, K.A., F. LOPERA, K. JONES, A. BECKER & R.A. SPERLING. 1998. Presenilin 1-associated abnormalities in regional cerebral perfusion. Neurobiol. Aging 19: S83.
31. 31. JOHNSON, K.A., K. JONES, B.L. HOLMAN, J. BECKER, P.A. SPIERS, A.. SATLIN & M.S. ALBERT. 1998. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 50: 1563-1571.
32. 32. KALARIA, R.N. & S.E. HARIK. 1989. Reduced glucose transporter at the blood brain barrier and in the cerebral cortex in Alzheimer's disease. J. Neurochem. 53: 1083-1088.
33. 33. KHACHATURIAN, Z.S. 1994. Calcium hypothesis of Alzheimer's disease and brain aging. Ann. N.Y. Acad. Sci. 747:1-11.
34. 34. KRISTIAN, T. & B.K. SIESJO. 1998. Calcium in ischemic cell death. Stroke 29: 705-718.
35. 35. LUITEN, P.G.M., G.I. DE JONG, E. FARKAS, J. PLASS, R. DE VOS &E.N. JANSEN. 1998. Cerebral microvascular breakdown in dementias and after experimental cerebral hypoperfusion. Neurobiol. Aging 19: S290.
36. 36. MANCARDI, G.L., F. PERDELLI, A. LEONARDI & O. BUGIANI. 1980. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol. 49: 79-83.
37. 2+ homeostasis and cell death. J. Neurosci. 15: 6239-6249.
38. 38. MARTIN, A.J., K.J. FRISTON, J.G. COLEBATCH & R. FRACKOWIAK. 1991. Decreases in regional cerebral blood flow with normal aging. J. Cerebr. Blood Flow Metab. 11: 684-689.
39. 39. MATTSON, M.P. 1997. Central role of oxyradicals in the mechanism of amyloid β-peptide cytotoxicity. Alzheimer's Dis. Rev. 2: 1-14.
40. 40. MATTSON, M.P., Q. GUO, K. FURUKAWA & W.A. PEDERSEN. 1998. Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70: 1-14.
41. 41. MEIER-RUGE, W. & C. BERTONI-FREDDARI. 1996. The significance of glucose turnover in the brain in the pathogenic mechanisms of Alzheimer's disease. Rev. Neurosci. 7: 1-19.
42. 42. NAGATA, K., R.J. BUCHAN, E. YOKOYAMA, Y. KONDOH & M. SATO. 1997. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann, N.Y. Acad. Sci. 826: 272-281.
43. 43. NEVE, R.L. & N.K. ROBAKIS. 1998. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21: 15-19.
44. 44. OHKURA, T., K. ISSE, K. AKAZAWA, M. HAMAMOTO, Y. YAOI & N. HAGINO. 1994. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr. J. 41: 361-371.
45. 45. PAPPAS, B.A., J.C. DE LA TORRE, C. DAVIDSON, M. KEYES & T. FORTIN. 1996. Chronic reduction of cerebral blood flow in the adult rat: late emerging CA1 cell loss and memory function. Brain Res. 708: 50-58.
46. 46. PERLMUTTER, L.S., M.A. MYERS & E. BARRON. 1994. Vascular basement membrane components and the lesions of Alzheimer's disease. Micros. Res. Tech. 28: 204-215.
47. 47. PROHOVNIK, I., R. MAYEUX, H. SACKHEIM & G. SMITH. 1998. Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology 38: 931-937.
48. erk converts tau into PHF-like form as found in Alzheimer's disease. Biochem. Biophys. Res. Commun. 193: 639-647.
49. 49. SALEHI, A. & D. SWAAB. 1998. Relationship between neuronal activity, neuropathological hallmarks and genetic background in Alzheimer's disease. Neurobiol. Aging 19: S5.
50. 50. SCHEIBEL, A.B., T. DUONG & O. TOMIYASU. 1986. Microvascular changes in Alzheimer's disease. In The Biological Substrates of Alzheimer's Disease.: 77-192. Academic Press. New York.
51. 51. SIMARD, D., J. OLESEN, O.B. PAULSON, N.A. LASSEN & E. SKINHOJ. 1971. Regional cerebral blood flow and its regulation in dementia. Brain 94: 273-287.
52. 52. SIMPSON, I.A., K.R. CHUNDU, T. DAVIES-HILL, W. HONER & P. DAVIES. 1994. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35: 546-551.
53. 53. SPERLING, R.A., K.J. JONES, D. RENTZ, M.S. ALBERT & D.L. HOLMAN. 1998. SPECT cerebral perfusion and apolipoprotein E genotype. Neurology 50: A438-A439.
54. 54. STIEBER, A., Z. MOURELATOS & N.D. GONATAS. 1996. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am. J. Pathol. 148: 415-426.
55. 55. SUO, Z., J. HUMPHREY, A. KUNDTZ, F. SETHI, F. CRAWFORD & M. MULLAN. 1998. Soluble Alzheimer's β-amyloid constricts the cerebral vasculature in vivo. Neurosci. Lett. 257: 77-80.
56. 56. TANIMUKAI, K., M. IMAIZUMI, K. KUDO, M. TOHYAMA & M. TAKEDA. 1998. Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Brain Res. Mol. Brain Res. 54: 212-218.
57. 57. TOHGI, H., H. YONEZAWA, S. TAKAHASHI & N. SATO. 1998. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 40: 131-137.
58. 58. VIJAYAN, V.K,. J. GEDDES, K. ANDERSON & H. CHAN-CHUI. 1980. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp. Neurol. 112: 72-78.
59. 59. VOLTERRA, A., D. TROTTI, C. TROMBA, S. FLORIDI & G. RACAGNI. 1994. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14: 2924-2932.
60. 60. WALDEMAR, G., P. HOCH & O.B. PAULSON. 1997. Functional brain imaging with single-photon emission computed tomography in the diagnosis of Alzheimer's disease. Int Psychogeriatr. 9: 223-227.
61. 61. WEST, M.J., P.D. COLEMAN, D.G. FLOOD & J.C. TRONCOSO. 1994. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. Lancet 344: 769-772.
62. 62. YAM, P.S., J. PATTERSON, D.I. GRAHAM, T. TAKASAGO, D. DEWAR & J. MCCULLOCH. 1998. Topographical and quantitative assessment of white matter injury following focal ischemic lesion in the rat brain. Brain Res. Brain Res. Protoc. 4: 315-322.
63. 63. YAM, P.S., T. TAKASAGO, D. DEWAR, D.I. GRAHAM & J. MCCULLOCH. 1997. Amyloid precursor protein accumulates in white matter at the margin of a focal ischemic lesion. Brain Res. 760: 150-157.